MedAvail : Investor Presentation

Transforming Today's Pharmacy

Investor Presentation I May 2023

NASDAQ: MDVL

Forward Looking Statement

MedAvail Holdings, Inc. ("MedAvail") cautions you that the statements in this presentation that are not a description of historical fact are forward-looking statements which may be identified by use of the words such as "anticipate," "believe," "expand," "expect," "grow," "intend," "opportunity," "plan," "potential," "project", "target" and "will" among others. These forward-looking statements are based on MedAvail's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of the ability to project future cash utilization and resources need for contingent future liabilities and business operations, the availability of sufficient resources for combined company operations and to conduct or continue planned product development activities, the ability to execute on commercial objectives, regulatory developments and the timing and ability of MedAvail to raise additional capital to fund operations, and other factors, including, but not limited to, those factors discussed in the section entitled "Risk Factors" of our most recent Annual Report on Form 10-K and on our Quarterly Reports Form 10-Q. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. We undertake no obligation to update any of these forward-looking statements for any reason, even if new information becomes available in the future, except as may be required by law. The extent to which the impact of general market and macroeconomic conditions, including the effect of inflationary pressure, including any impact of adverse developments affecting the financial services industry, such as those based on liquidity constraints or concerns and events including the outbreak of war in Ukraine, has on MedAvail's businesses, operations, and financial results, including the duration and magnitude of such effects, will depend on numerous factors, which are unpredictable and how quickly and to what extent normal economic and operating conditions are affected or impacted. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. MedAvail undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.

2

Mission Statement

To improve patients' lives by expanding access to

medications through innovative technology where and

when they need them

Investment Highlights

Innovative pharmacy technology company with clear roadmap to delivering profitable and sustainable growth

01

02

03

Addresses significant unmet needs in the pharmacy space

Demonstrable positive impact on Rx adherence and reimbursement

Strategic partnerships to drive future deployments across multiple channels

04

05

06

Significant total and serviceable addressable markets

Recurring, high-margin predictable revenue stream

Strengthened financial position with projected 2+ years of cash on-hand

4

The Current Patient Journey

Demonstrates a significant unmet need in today's pharmacy

Patient prescribed an Rx at a Clinic	Patient must drive to a retail pharmacy	Shortage of pharmacists/
to have the Rx filled	pharmacy techs causes:
or Urgent Care
Rx is transmitted to a retail	Many patients do not have access to	Long wait times (avg. 30 minutes)
pharmacy	reliable transportation	Limited pharmacy hours

Improved access increase outcomes and satisfaction while simplifying provider's

practice and increasing reimbursement

5